Navigation Links
China BioPharmaceutical Industry - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Date:8/13/2014

DALLAS, Aug. 13, 2014 /PRNewswire-iReach/ -- The report on Pharmaceutical Industry in China provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The "Pharmaceutical Industry in China – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges" report is supported by over 199 tables & figures within 153 pages.

Logo - http://photos.prnewswire.com/prnh/20140813/135771

The Chinese biopharmaceutical market is presented as follows:

  • By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
  • By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)

A wealth of financial information is provided including:

  • Company financials, sales & revenue figures – historical to Q2•2013
  • China GDP, economic growth, export (bulk drug, formulations) figures
  • Indian health expenditure as a function of GDP
  • Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
  • Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
  • Projected figures of strategic emerging industry GDP percentage contribution

Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=291985.

SWOT, Economic and Business Environment specifics include:

  • Key strengths, weaknesses and threats influencing leading player position within the market
  • Top Five Contract Pharmaceutical Export Markets of China
  • Major players within China's leading therapeutic markets (e.g., cancer, allergy, liver disease)
  • Multinational penetration into the Chinese Pharma Market
  • Comprehensive product portfolios, R&D activity and pipeline therapeutics
  • M&A activity and future strategies of top Chinese pharmacos
  • Economic indicators, trade policy, merchandise and commercial trade statistics
  • Gross Domestic Product of China, historic and projection analysis
  • Chinese economic outlook in comparison to advanced economies
  • Three Tier 'Pharmerging' Markets with Potential for Significant Growth
  • Prescription drug sales distribution channels in China
  • Major biogeneric products in China

This report highlights a number of significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy.

  • Amoytop Biotech
  • Active Pharmaceutical Products
  • Beijing Continent Pharmaceuticals
  • FusoGen Pharmaceuticals
  • Shanghai Huaguan Biochip
  • SiBiono GeneTech
  • Abbott
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson Medical
  • Merck
  • Novartis
  • Pfizer
  • Roche

Forecast projections and future growth rates are provided to give you a forthcoming perspective of this growing industry. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.

What you will gain:

  • An in-depth understanding of the Chinese biopharmaceutical market and it's environment
  • Current market facts, figures and product lines of key players in the industry
  • An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market
  • Knowledge of how the Chinese pharma market will integrate into the global healthcare market
  • Information on key regulatory and government policies
  • Data on levels of private and publically funded biopharma studies in China
  • Strategies on how to adapt and restructure current business models to this industry

This report tackles key concerns to the Chinese biopharmaceutical market such as:

  • Lack of regulatory policy and legislation
  • Reimbursement schemes and payers concerns
  • Funding and government sponsorship issues
  • International scepticism of Chinese safety and efficacy therapeutic profiles

This report will tell you if the companies mentioned are:

  • Strong, competitive players
  • Pooling their resources for specific growth and therapeutic areas
  • Investing strategically in R&D
  • Have a history of strategic M&A activity

Table of Contents

1.0 Summary

2.0 Chronic Disease Prevalence Statistics

3.0 Business Environment

4.0 Chinese Pharmaceutical Market

5.0 Government and Regulation Environment

6.0 China – Third Largest Pharma Market 2012

7.0 Global Pharmaceutical Companies Interest in China

8.0 Chinese Pharmaceutical Companies

9.0 Drivers, Restraints, Challenges and Opportunity Analysis

List of Tables

List of Figures

Explore Other Reports by Kelly Scientific Publications:

  1. Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment: This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 263 tables & figures over 224 pages.
  2. Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis): A comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment.
  3. Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines: A comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle within domestic and international therapeutic markets. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.
  4. Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013: The study reveals market figures of the overall Indian pharmaceutical market and sub-markets and is supported by over 330 exhibits. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need. Not limited to the biotechnology industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, consumer goods, environment, medical devices, healthcare, food and beverages, retail, water, advanced materials and much more.

Media Contact: Ritesh Tiwari, ReportsnReports.com, + 1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports.com
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. China Trauma Fixation Market Outlook, Size, Share, Analysis, and Forecast to 2020
2. Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
3. Consumer Health in Hong Kong, China
4. Health and Wellness in China
5. China Biologic Reports Financial Results for the Second Quarter of 2014
6. China Ureteroscopes Market Outlook to 2020
7. Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care
8. China Nepstar Chain Drugstore to Report Second Quarter 2014 Financial Results on August 28, 2014
9. China Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
10. Global & China Market: Glucosamine, Coenzyme Q10 & Cysteine Methyl Ester
11. Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... ... July 07, 2020 , ... With ... Navajo Nation residents, the 33 nonprofits who received the latest ISA Foundation ... round of funding, the foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) ...
(Date:7/4/2020)... , ... July 03, 2020 , ... By Heidi Jean ... we’ve retreated into our homes for cover, Assuaged, Inc. is going full ... all over the globe this year to get their feet wet in marketing, social ...
(Date:7/2/2020)... ... July 02, 2020 , ... Realty ONE Group ... health series on its live agent Town Halls, furthering its commitment to its ... series includes special guests and Realty ONE Group leadership discussing social, mental, physical ...
Breaking Medicine Technology:
(Date:7/2/2020)... ... July 02, 2020 , ... Temprian, ... of autoimmune diseases. Its lead indication is vitiligo. Vitiligo patients develop progressive ... , While vitiligo is equally prevalent in all ethnic groups, it ...
(Date:7/2/2020)... SHELTON, Conn. (PRWEB) , ... July 02, 2020 ... ... closure of many businesses, including dental offices for non-emergency work. In conjunction with ... released reopening guidelines for Connecticut dental practices in mid-May. , Due to ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to Improve Diagnosis ... at the University of Massachusetts Medical School- Baystate and Ann Gaffey, RN, MSN, ... Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in May and ...
(Date:6/28/2020)... ... , ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use ... of PD-L1 expression to assess response in patients treated with Bristol Myers Squibb’s PD-1 ... Cancer Research (AACR) Annual Meeting. AACR was held June 22 to June 24. , ...
(Date:6/28/2020)... , ... June 27, 2020 , ... ... Classroom, the first online, full-day educational conference in the organization’s history. The online ... facioscapulohumeral muscular dystrophy (FSHD), which was cancelled this year due to COVID-19. Nearly ...
Breaking Medicine News(10 mins):